2026 #NLASessions Expert Theater Lineup
Expert Theaters are industry supported, non CME educational sessions held during designated breaks in the official meeting schedule. These focused programs feature thought leaders and clinical experts who dive into timely topics in lipid management, cardiovascular risk reduction, and emerging therapies.
Attendance is open to all registered meeting participants and food and beverages (provided by the NLA) are offered at every Expert Theater.
Thursday, June 11 | 3:00-3:50pm CT
Break food and beverage provided by the NLA
Advancing LDL-C Management in Pediatric and Adult HoFH
Sheraton Ballroom 3 | Sponsored by Chiesi Global Rare Disease
Speakers
Assistant Professor of Clinical Medicine
Physician, Corporal Michael J. Crescenz Philadelphia VA Medical Center
Director, Clinical Trials, Penn Medicine Center for Preventive Cardiology and Lipid Management
Michael Minicucci
Patient Ambassador
Redefining Risk: Leveraging CCTA and Plaque Analysis for Personalized Cardiovascular Prevention
Sheraton Ballroom 2 | Sponsored by Heartflow
This Expert Theater will cover the use of CCTA and Heartflow Plaque Analysis for precise cardiovascular risk stratification, focusing on identifying patient populations, providing practical insights into clinical integration, and exploring the future of plaque-focused prevention strategies.
Speakers
Nihar R. Desai, MD, MPH, FNLA
Associate Professor of Medicine
Yale School of Medicine
Vice Chief, Section of Cardiovascular Medicine
Investigator, Center for Outcomes Research and Evaluation
New Haven, CT
Sarah Rinehart, MD, FACC, FSCC
Medical Director Cardiac Imaging Center
CV CT, Lipid/Prevention Clinic
Charleston Area Medical Center
Charleston, WV
Friday, June 12 | 12:25-1:15pm CT
Lunch provided by the NLA
TRYNGOLZA: proven results and real-patient experiences
Sheraton Ballroom 2 | Sponsored by Ionis Pharmaceuticals
Please join Dr. Eliot Brinton at NLA's 2026 Scientific Sessions for a presentation on TRYNGOLZA®, the first FDA-approved therapy for adults with familial chylomicronemia syndrome (FCS) as an adjunct to diet.
Speaker
University of Utah School of Medicine
Moderator
Baltimore, MD
Speaker
Medical Director, Lipid Apheresis Unit
University of Colorado School of Medicine
Aurora, CO
Saturday, June 13 | 8:00-8:50am CT
Breakfast provided by the NLA
Redemplo® (plozasiran): A Treatment to Lower Triglycerides in Adults With Familial Chylomicronemia Syndrome (FCS)
Sheraton Ballroom 2 | Sponsored by Arrowhead Pharmaceuticals, Inc.
Speaker
Uncover HoFH, an ultra-rare lipid disorder, and Explore EVKEEZA (evinacumab-dgnb) as a treatment option
Sheraton Ballroom 3 | Sponsored by Regeneron
This Expert Theater will cover the use of CCTA and Heartflow Plaque Analysis for precise cardiovascular risk stratification, focusing on identifying patient populations, providing practical insights into clinical integration, and exploring the future of plaque-focused prevention strategies.
Speaker
Alan S. Brown, MD, MPH, MNLA
Saturday, June 13 | 12:35-1:25pm CT
Lunch provided by the NLA
Identification and Stratification of Patients at High CV Risk without a Prior MI or Stroke: Insights from Real-World Evidence and the VESALIUS-CV Trial
Sheraton Ballroom 3 | Sponsored by Amgen
Join a cardiovascular expert as they explore how to reduce the risk of MACE in patients at high CV risk without a previous MI or stroke. Featuring data from the VESALIUS-CV outcomes trial alongside real-world evidence, this session highlights the urgent need for risk identification and treatment.
Please join our presentation on the unmet need, urgent risks associated with sHTG, and expert recommendations for managing patients with triglycerides ≥500 mg/dL.
Speaker
Severe Hypertriglyceridemia (sHTG) | An Underrecognized, Life-Threatening Disease
Sheraton Ballroom 2 | Sponsored by Ionis Pharmaceuticals
Please join our presentation on the unmet need, urgent risks associated with sHTG, and expert recommendations for managing patients with triglycerides ≥500 mg/dL.